Physician profile
John A Ashkar
NPI 1073568184
$29,351.27
in general payments reported to CMS, 2019-2025
50 companies · $3,148 in 2025
The $3,148 reported for 2025 was more than what 83% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,505 · 2020: $4,109 · 2021: $3,604 · 2022: $3,143 · 2023: $3,314 · 2024: $2,528 · 2025: $3,148.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,781 · Education: $209.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,780.92 |
| Education | $209.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sunovion Pharmaceuticals INC. | $4,956.18 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $4,483.55 | 2019-2025 | Fasenra, Tezspire, Airsupra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $4,442.79 | 2019-2025 | Ofev, Jardiance, Spiriva Respimat |
| Glaxosmithkline, LLC. | $2,357.26 | 2019-2025 | Trelegy Ellipta, Arexvy, Nucala |
| Regeneron Healthcare Solutions, INC. | $1,284.93 | 2019-2025 | Dupixent |
| Philips North America LLC | $1,056.21 | 2019-2025 | Vest Therapy Und, (Ak6) Vest Therapy |
| Actelion Pharmaceuticals US, INC. | $948.74 | 2019-2025 | Opsumit, Uptravi |
| Pfizer INC. | $886.17 | 2019-2025 | |
| Amgen INC. | $859.14 | 2019-2025 | Tezspire, Repatha, Repatha |
| Genzyme Corporation | $842.75 | 2019-2025 | |
| Insmed, INC. | $761.80 | 2019-2025 | Arikayce, Brinsupri |
| Genentech USA, INC. | $594.66 | 2019-2024 | Xolair |
| Mylan Specialty L.P. | $543.02 | 2019-2024 | Yupelri |
| Novartis Pharmaceuticals Corporation | $454.68 | 2019-2024 | |
| Advanced Respiratory, INC | $436.94 | 2019-2021 |
Show all 50 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Graphics Corporation | $410.35 | 2020 | |
| Electromed, INC. | $340.76 | 2019-2025 | Smartvest |
| Mallinckrodt Hospital Products INC. | $294.06 | 2020-2025 | Acthar |
| Verona Pharma, INC. | $291.78 | 2025 | Ohtuvayre |
| Merck Sharp & Dohme LLC | $277.45 | 2019-2022 | |
| Phathom Pharmaceuticals, INC. | $247.92 | 2024-2025 | Voquezna |
| Inogen, INC. | $234.79 | 2022-2024 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Paratek Pharmaceuticals, INC. | $228.85 | 2023-2024 | Nuzyra |
| Sanofi-Aventis U.S. LLC | $198.98 | 2019-2025 | |
| Baxter Healthcare | $194.72 | 2022-2024 | Hillrom - Vest System Model 105 Home Care |
| United Therapeutics Corporation | $181.84 | 2021-2025 | Tyvaso, Orenitram, Tyvaso |
| Lilly USA, LLC | $171.84 | 2019-2023 | Mounjaro, Jardiance |
| Viatris Specialty LLC | $157.96 | 2025 | Yupelri |
| Hologic Sales and Service, LLC | $125.00 | 2019 | |
| Abiomed | $101.64 | 2025 | |
| Abbvie INC. | $94.14 | 2019-2025 | Linzess |
| Teva Pharmaceuticals USA, INC. | $87.44 | 2021-2022 | |
| Amarin Pharma, INC. | $87.31 | 2019-2020 | |
| Alexion Pharmaceuticals, INC. | $80.48 | 2021-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $76.60 | 2019 | |
| Abbott Laboratories | $70.07 | 2021 | |
| Jazz Pharmaceuticals INC. | $61.53 | 2020-2021 | |
| Circassia INC. | $51.99 | 2019 | |
| Novo Nordisk INC | $51.80 | 2020-2021 | |
| Resmed Corp | $50.64 | 2024-2025 | |
| Grifols USA, LLC | $42.45 | 2019 | |
| Phadia US INC. | $40.40 | 2023 | Immunocap |
| Bayer Healthcare Pharmaceuticals INC. | $40.08 | 2019-2023 | |
| Axsome Therapeutics, INC. | $27.69 | 2023 | Sunosi |
| Boston Scientific Corporation | $26.66 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $24.28 | 2019 | |
| Janssen Pharmaceuticals, INC | $21.79 | 2019 | |
| Allergan, INC. | $17.50 | 2019 | |
| Csl Behring | $16.82 | 2019 | |
| Arbor Pharmaceuticals, INC. | $14.84 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Ashkar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.